Abstract
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery. Thereby, only a specific amount of the tissue below the resection surface, the clinically defined margin width, should be assessed. Since the imaging depth of hyperspectral imaging varies with wavelength and tissue composition, this can have consequences for the clinical use of hyperspectral imaging as margin assessment technique. In this study, a method was developed that allows for hyperspectral analysis of resection margins in breast cancer. This method uses the spectral slope of the diffuse reflectance spectrum at wavelength regions where the imaging depth in tumor and healthy tissue is equal. Thereby, tumor can be discriminated from healthy breast tissue while imaging up to a similar depth as the required tumor-free margin width of 2 mm. Applying this method to hyperspectral images acquired during surgery would allow for robust margin assessment of resected specimens. In this paper, we focused on breast cancer, but the same approach can be applied to develop a method for other types of cancer.
Original language | English |
---|---|
Article number | e201900086 |
Journal | Journal of biophotonics |
Volume | 12 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1 Nov 2019 |
Externally published | Yes |
Funding
information KWF Kankerbestrijding, Grant/Award Number: grant KWF 10747The authors gratefully acknowledge the financial support of this research by the KWF Kankerbestrijding (grant KWF 10747). The authors thank the NKI-AVL core Facility Molecular Pathology & Biobanking (CFMPB) for supplying NKI-AVL biobank material and all pathologist assistants from the Department of Pathology and all surgeons and nurses from the Department of Surgery for their assistance in collecting the specimens.
Funders | Funder number |
---|---|
CFMPB | |
Department of Pathology | |
NKI-AVL core Facility Molecular Pathology & Biobanking | |
KWF Kankerbestrijding | KWF 10747 |